2[1]ESCOP. "Hyperici herba" monographs on the medicinal uses of plant drugs[M]. Exeter, U.K.: European Scientific Cooperative on Phytotherapy, 1997.
3[2]Kleber E, Obry T, Hippeli S, et al. Biochemical activities of extracts from Hypericum perforatum L.. 1st communication: inhibition of dopamine-beta-hydroxylase[J]. Arzneimittelforschung, 1999, 49(2): 106-109.
4[3]Thiede HM, Walper A. Inhibition of MAO and COMT by hypericum extracts and hypericin[J]. Psychiatry Neurol, 1994, 7(Suppl 1): S54-56.
5[4]Denke A, Schneider W, Elstner EF. Biochemical activities of extracts from Hypericum perforatum L.. 2nd communication: inhibition of metenkephaline- and tyrosine-dimerization[J]. Arzneimittelforschung, 1999, 49(2): 109-114.
6[5]Chatterjee SS, Bhattacharya SK, Wonnemann M, et al. Hyperforin as a possible antidepressant component of hypericum extracts[J]. Life Sci, 1998, 63(6): 499-510.
7[6]Laakmann G, Jahn G, Schule C. Hypericum perforatum extract in treatment of mild to moderate depression. Clinical and pharmacological aspects[J]. Nervenarzt, 2002, 73(7): 600-612.
8[7]Jensen AG, Hansen SH, Nielsen E. Adhyperforin as a contributor to the effect of Hypericum perforatum L. in biochemical models of antidepressant activity[J]. Life Sci, 2001, 68(14): 1593-1605.
9[8]Linde K, Ramirez G, Mulrow CD, et al. St John's wort for depression--an overview and meta-analysis of randomised clinical trials[J]. BMJ, 1996, 313(7052): 253-258.
10[9]Volz HP. Controlled clinical trials of Hypericum extracts in depressed patients--an overview[J]. Pharmacopsychiatry, 1997, 30(Suppl 2): 72-76.
